Las Vinas is a 38MW onshore wind power project. It is located in Castile and León, Spain. According to GlobalData, who tracks and profiles over 170,000 power plants worldwide, the project is currently active. It has been developed in multiple phases. Post completion of construction, the project got commissioned in 2010. Buy the profile here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Las Vinas

Buy the Profile

Data Insights

The gold standard of business intelligence.

Find out more

Description

The project is developed and owned by Iberdrola. The company has a stake of 95%.

Development status

The project is currently active. The project got commissioned in 2010.

Contractors involved

Siemens Gamesa Renewable Energy was selected as the turbine supplier for the wind power project. The project consists of 19 units of G87-2.0 MW turbines, each with 2MW nameplate capacity.

For more details on Las Vinas, buy the profile here.

About Iberdrola

Iberdrola SA (Iberdrola) is an energy utility. It constructs, operates and manages power generation plants, transmission and distribution facilities and other assets. The company produces electricity using conventional and renewable energy sources. It also trades electricity and gas in wholesale markets; and retails electricity, gas, and other related products and services. Iberdrola retails energy to residential, commercial, industrial, institutional and other customers. In its transition to a sustainable energy model, the company actively invests in smart grids, renewable energy, large-scale energy storage and digital transformation. Iberdrola operates in Europe, North America, South America and other regions. Iberdrola is headquartered in Bilbao, Vizcaya, Spain.

This content was updated on 14 October 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.